A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation

A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation

10.1016/j.canlet.2016.07.023

Saved in:
Bibliographic Details
Main Authors: Ong, Pei-Shi, Wang, Lingzhi, Chia, Deborah Miao-Hui, Seah, Jolyn Yu-Xin, Kong, Li-Ren, Thuya, Win-Lwin, Chinnathambi, Arunachalam, Lau, Jie-Ying Amelia, Wong, Andrea Li-Ann, Yong, Wei-Peng, Yang, Daiwen, Ho, Paul Chi-Lui, Sethi, Gautam, Goh, Boon-Cher
Other Authors: BIOLOGY (NU)
Format: Article
Language:English
Published: ELSEVIER IRELAND LTD 2020
Subjects:
Science & Technology
Life Sciences & Biomedicine
Oncology
Belinostat (R)
Seliciclib (R)
Non-small cell lung cancer
Caspase-8 activation
Truncated BID
HISTONE DEACETYLASE INHIBITORS
DEPENDENT KINASE INHIBITOR
DEATH
P53
FLAVOPIRIDOL
ENHANCEMENT
CARBOPLATIN
ROSCOVITINE
EXPRESSION
PACLITAXEL
Online Access:https://scholarbank.nus.edu.sg/handle/10635/175510
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English

Internet

https://scholarbank.nus.edu.sg/handle/10635/175510

Similar Items